Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neptune Wellness Solutions Inc NEPTF

Neptune Wellness Solutions Inc. is a consumer-packaged goods company that is primarily focused on health and wellness products. The Company focuses on developing a portfolio of consumer products that align with the market trends for natural, sustainable, plant-based, and purpose-driven lifestyle brands. Its products are available in more than 29,000 retail locations and include organic food and beverage brands, such as Sprout Organics, Nosh, and Nurturme, as well as nutraceuticals brands like Biodroga and Forest Remedies. Its main brand units are nutraceuticals and organic foods and beverages. The Company sells its nutraceutical products mainly in bulk soft gels or liquids to multiple distributors and customers, who commercialize these products under their private label. The Company, through its Sprout subsidiary, sells its organic foods and beverages products to mass retailers, grocery stores and other retail outlets, as well as online through e-commerce sites and its own Website.


PINL:NEPTF - Post by User

Post by gwrbion Jun 05, 2009 11:08am
382 Views
Post# 16046915

Bayer deal

Bayer deal
This is the real deal, the "pharma deal" that will legitimize everything the "longs" have been waiting for.  This will get the attention of those with significant capital, and should be a springboard to achieve the listing requirements for the TSX, which will bring on the institutions.

The Company should take full advantage of this as a PR opportunity - and totally play on the technology story from a small Canadian start-up to partnering with a major pharma.  This should be in the papers and on BNN.

Not sure what they had to give up to get this thing signed - as details are few.  Nevetheless, the trend is significantly up from here (once the short term money cashes out). 

Look for Cleland to come out of his shell now, and look forward to reading his article mid-June about the investment merits for NTB - now that this deal has come out.

Lets hope there are more details coming out of next week's AGM.



Bullboard Posts